Publikationen Pädiatrische Pneumologie, Mukoviszidose, Sportmedizin

Hebestreit H, Thornton CS (2023)
Cystic fibrosis and the cardiovascular system: the unexpected heartache.
Eur Respir J. 2023 Oct 26;62(4):2301253.
Zur Publikation

Heidenreich JF, Kuhl PJ, Grunz JP, Hendel R, Metz C, Weng AM, Benkert T, Hebestreit H, Bley TA, Köstler H, Veldhoen S (2023)
Lung Function in Patients with Cystic Fibrosis before and during CFTR-Modulator Therapy Using 3D Ultrashort Echo Time MRI.
Radiology. 2023 Jul;308(1):e230084.
Zur Publikation

Jung R, Zürcher SJ, Schindera C, Eser P, Meier C, Schai A, Braun J, Deng WH, Hebestreit H, Neuhaus C, Schaeff J, Rueegg CS, von der Weid NX, Kriemler S (2023)
Effect of a physical activity intervention on lower body bone health in childhood cancer survivors: A randomized controlled trial (SURfit).
Int J Cancer. 2023 Jan 15;152(2):162-171.
Zur Publikation

Radtke T, Kriemler S, Stein L, Karila C, Urquhart DS, Orenstein DM, Lands LC, Schindler C, Eber E, Haile SR, Hebestreit H; ACTIVATE-CF Study Working Group (2023)
Cystic fibrosis related diabetes is not associated with maximal aerobic exercise capacity in cystic fibrosis: a cross-sectional analysis of an international multicenter trial.
J Cyst Fibros. 2023 Jan;22(1):31-38.
Zur Publikation

Rueegg CS, Zürcher SJ, Schindera C, Jung R, Deng WH, Bänteli I, Schaeff J, Hebestreit H, von der Weid NX, Kriemler S (2023)
Effect of a 1-year physical activity intervention on cardiovascular health in long-term childhood cancer survivors-a randomised controlled trial (SURfit).
Br J Cancer. 2023 Oct;129(8):1284-1297.
Zur Publikation

Saynor ZL, Gruet M, McNarry MA, Button B, Morrison L, Wagner M, Sawyer A, Hebestreit H, Radtke T, Urquhart DS; European Cystic Fibrosis Society Exercise Working Group (2023)
Guidance and standard operating procedures for functional exercise testing in cystic fibrosis.
Eur Respir Rev. 2023 Aug 9;32(169):230029.
Zur Publikation

Urquhart DS, Hebestreit H, Saynor Z, Radtke T; European Cystic Fibrosis Society Exercise Working Group (2023)
'Gold-standard' field test is a non-sequitur.
Pulmonology. 2023 Mar-Apr;29(2):173.
Zur Publikation

Hebestreit H, Kriemler S, Schindler C, Stein L, Karila C, Urquhart DS, Orenstein DM, Lands LC, Schaeff J, Eber E, Radtke T; ACTIVATE-CF Study Working Group (2022) 
Effects of a partially supervised conditioning program in cystic fibrosis: An international multicentre randomized controlled trial (ACTIVATE-CF). 
Am J Respir Crit Care Med 2022;205(3):330-339.

Hebestreit H, Zeidler C, Schippers C, de Zwaan M, Deckert J, Heuschmann P, Krauth C, Bullinger M, Berger A, Berneburg M, Brandstetter L, Deibele A, Dieris-Hirche J, Graeßner H, Gündel H, Herpertz S, Heuft G, Lapstich A-M, Lücke T, Maisch T, Mundlos C, Petermann-Meyer A, Müller S, Ott S, Pfister L, Quitmann J, Romanos M, Rutsch F, Schaubert K, Schubert K, Schulz JB, Schweiger S, Tüscher O, Ungethüm K, Wagner TOF, Haas K, ZSE-DUO working group (2022)
Dual guidance structure for evaluation of patients with unclear diagnosis in centers for rare diseases (ZSE-DUO): study protocol for a controlled multi-centre cohort study. 
Orphanet J Rare Dis 2022;17(1):47. 

Lorenz D, Musacchio T, Kunstmann E, Grauer E, Pluta N, Stock A, Speer CP, Hebestreit H (2022) 
A case report of Sanfilippo syndrome - the long way to diagnosis. 
BMC Neurol 2022;22(1):93.

Niemitz M, Gaber AM, Goldbeck L, Wallenwein A, Tutus D, Fegert JM, Smaczny C, Heuer HE, Junge S, Hebestreit H, Schlangen M (2022)
Professional quality of life among health care professionals in cystic fibrosis and child and adolescent mental health. 
J Workplace Behav Health 2022;37(1):9-30.

Radtke T, Kriemler S, Stein L, Karilla C, Urquhart DS, Orenstein DM, Lands LC, Schindler C, Eber E, Haile SR, Hebestreit H (2022) 
Cystic fibrosis related diabetes is not associated with maximal aerobic exercise capacity in cystic fibrosis: a cross-sectional analysis of an international multicenter trial (ACTIVATE-CF).
J Cyst Fibros 2022 (accepted for publication)

Schippers C, Volk D, deZwaan M, Deckert J, Dieris-Hirche J, Herpertz S, Schulz JB, Hebestreit H, ZSE-DUO Arbeitsgruppe (2022) 
ZSE-DUO – duale Lotsenstruktur im Zentrum für Seltene Erkrankungen. 
Innere Medizin 2022;63:791–797. 

Hebestreit H (2021)
Zentren für Seltene Erkrankungen – Strukturen, Aufgaben und Netzwerke.
Gefäßchirurgie 2021;26(8):577-582.

Hebestreit H, Ullrich M, Graeßner H, Rashid A, Ertl M, Maisch T (2021)
Digitale Systeme für Konsile und Fallkonferenzen bei Seltenen Erkrankungen. 
Monatsschr Kinderheilkd 2021;169:705-710.

Kunz AS, Weng AM, Wech T, Knapp J, Petritsch B, Hebestreit H, Bley TA, Köstler H, Veldhoen S (2021)
Non-contrast pulmonary perfusion MRI in patients with cystic fibrosis. 
Eur J Radiol 2021;139:109653.

Lorenz D, Kress W, Zaum AK, Speer CP, Hebestreit H (2021)
Report of two siblings with spondylodysplastic Ehlers-Danlos syndrome and B4GALT7 deficiency. 
BMC Pediatr 2021;21(1):293.

Veldhoen S, Heidenreich JF, Metz C, Petritsch B, Benkert T, Hebestreit HU, Bley TA, Köstler H, Weng AM (2021)
Three-dimensional ultrashort echotime magnetic resonance imaging for combined morphologic and ventilation imaging in pediatric patients with pulmonary disease. 
J Thorac Imaging 2021;36(1):43-51.

Hartmann M,· Meyer M, ·Brudy L, Oberhoffer-Fritz R, Böhm R, Hebestreit H, Hansmann S (2020) 
Bewegung und Sport bei chronischen Erkrankungen.
Monatsschr Kinderheilkd. 2020;168(8):703-714.

Heidenreich JF, Weng AM, Metz C, Benkert T, Pfeuffer J, Hebestreit H, Bley TA, Köstler H, Veldhoen S (2020)
Three-dimensional ultrashort echo time MRI for functional lung imaging in cystic fibrosis. 
Radiology. 2020;296(1):191-199.

Lodes N, Seidensticker K, Perniss A, Nietzer S, Oberwinkler H, May T, Walles T, Hebestreit H, Hackenberg S, Steinke M (2020)
Investigation on ciliary functionality of different airway epithelial cell lines in three-dimensional cell culture.
Tissue Eng Part A. 2020;26(7-8):432-440.

Nentwich J, Ruf K, Girschick H, Holl-Wieden A, Morbach H, Hebestreit H, Hofmann C (2020)
Correction to: Physical activity and health-related quality of life in chronic non-bacterial osteomyelitis.
Pediatr Rheumatol Online J. 2020;18(1):11.

Seidl E, Carlens J, Schwerk N, Wetzke M, Marczak H, Lange J, Krenke K, Mayell SJ, Escribano A, Seidenberg J, Ahrens F, Hebestreit H, Nährlich L, Sismanlar T, Aslan AT, Snijders D, Ullmann N, Kappler M, Griese M (2020)
Persistent tachypnea of infancy: Follow up at school age.
Pediatr Pulmonol. 2020;55(11):3119-3125. 

Hebestreit H, Hulzebos EH, Schneiderman JE, Karila C, Boas SR, Kriemler S, Dwyer T, Sahlberg M, Urquhart DS, Lands LC, Ratjen F, Takken T, Varanistkaya L, Rücker V, Hebestreit A, Usemann J, Radtke T; Prognostic value of CPET in CF study group (2019) Cardiopulmonary exercise testing provides additional prognostic information in cystic fibrosis.
Am J Respir Crit Care Med 2019;199:987-995.

Kampouras A, Hatziagorou E, Avramidou V, Georgopoulou V, Kirvassilis F, Hebestreit H, Tsanakas J (2019)
Ventilation efficiency to exercise in patients with cystic fibrosis.
Pediatr Pulmonol 2019;54:1584-1590.

Lodes N, Seidensticker K, Perniss A, Nietzer S, Oberwinkler H, May T, Walles T, Hebestreit H, Hackenberg S, Steinke M (2019)
Investigation on Ciliary Functionality of Different Airway Epithelial Cell Lines in Three-Dimensional Cell Culture.
Tissue Eng Part A 2019;26:432-440.

Nentwich J, Ruf K, Girschick H, Holl-Wieden A, Morbach H, Hebestreit H, Hofmann C (2019)
Physical activity and health-related quality of life in chronic non-bacterial osteomyelitis.
Pediatr Rheumatol Online J 2019;17:45.

Radtke T, Crook S, Kaltsakas G, Louvaris Z, Berton D, Urquhart DS, Kampouras A, Rabinovich RA, Verges S, Kontopidis D, Boyd J, Tonia T, Langer D, De Brandt J, Goërtz YMJ, Burtin C, Spruit MA, Braeken DCW, Dacha S, Franssen FME, Laveneziana P, Eber E, Troosters T, Neder JA, Puhan MA, Casaburi R, Vogiatzis I, Hebestreit H (2019)
ERS statement on standardisation of cardiopulmonary exercise testing in chronic lung diseases.
Eur Respir Rev 2019;28:80101.

Radtke T, Vogiatzis I, Urquhart DS, Laveneziana P, Casaburi R, Hebestreit H; European Respiratory Society Task Force on Standardisation of Cardiopulmonary Exercise Testing in Chronic Lung Diseases (2019)
Standardisation of cardiopulmonary exercise testing in chronic lung diseases: summary of key findings from the ERS task force.
Eur Respir J 2019;54:1901441.

Ruf K, Beer M, Köstler H, Weng AM, Neubauer H, Klein A, Platek K, Roth K, Beneke R, Hebestreit H (2019)
Size-adjusted muscle power and muscle metabolism in patients with cystic fibrosis are equal to healthy controls - a case control study.
BMC Pulm Med 2019;19:269.

Ruf K, Thomas W, Brunner M, Speer CP, Hebestreit H (2019)
Diverging effects of premature birth and bronchopulmonary dysplasia on exercise capacity and physical activity - a case control study.
Respir Res 2019;20:260.

Avramidou V, Hatziagorou E, Kampouras A, Hebestreit H, Kourouki E, Kirvassilis F, Tsanakas J (2018) 
Lung clearance index (LCI) as a predictor of exercise limitation among CF patients.
Pediatr Pulmonol 2018;53:81-87

Ballmann M, Hubert D, Assael BM, Staab D, Hebestreit A, Naehrlich L, Nickolay T, Prinz N, Holl RW; CFRD Study Group (2018) 
Repaglinide versus insulin for newly diagnosed diabetes in patients with cystic fibrosis: A multicentre, open-label, randomised trial.
Lancet Diabetes Endocrinol 2018;6:114-121

Hebestreit H, Hulzebos EH, Schneiderman JE, Karila C, Boas SR, Kriemler S, Dwyer T, Sahlberg M, Urquhart DS, Lands LC, Ratjen F, Takken T, Varanistkaya L, Rücker V, Hebestreit A, Usemann J, Radtke T; Prognostic value of CPET in CF study Group (2018) 
Cardiopulmonary exercise testing provides additional prognostic information in cystic fibrosis.
Am J Respir Crit Care Med 2018 doi: 10.1164/rccm.201806-1110OC [Epub ahead of print]

Hebestreit H, Lands LC, Alarie N, Schaeff J, Karila C, Orenstein DM, Urquhart DS, Hulzebos EHJ, Stein L, Schindler C, Kriemler S, Radtke T; ACTIVATE-CF Study Working Group (2018) 
Effects of a partially supervised conditioning programme in cystic fibrosis: an international multi-centre randomised controlled trial (ACTIVATE-CF): Study protocol.
BMC Pulm Med 2018;18:31

Radtke T, Hebestreit H, Gallati S, Schneiderman JE, Braun J, Stevens D, Hulzebos EH, Takken T, Boas SR, Urquhart DS, Lands LC, Tejero S, Sovtic A, Dwyer T, Petrovic M, Harris RA, Karila C, Savi D, Usemann J, Mei-Zahav M, Hatziagorou E, Ratjen F, Kriemler S; CFTR-Exercise study Group (2018) 
CFTR genotype and maximal exercise capacity in cystic fibrosis: A cross-sectional study.
Ann Am Thorac Soc 2018;15:209-216

Ruf K, Demerath A, Hebestreit H, Kunzmann S (2018) 
Is sweat testing for cystic fibrosis feasible in patients with down syndrome?
BMC Pulm Med 2018;18:8

Schwarz C, Schulte-Hubbert B, Bend J, Abele-Horn M, Baumann I, Bremer W, Brunsmann F, Dieninghoff D, Eickmeier O, Ellemunter H, Fischer R, Grosse-Onnebrink J, Hammermann J, Hebestreit H, Hogardt M, Hügel C, Hug M, Illing S, Jung A, Kahl B, Koitschev A, Mahlberg R, Mainz JG, Mattner F, Mehl A, Möller A, Muche-Borowski C, Nüßlein T, Puderbach M, Renner S, Rietschel E, Ringshausen FC, Schmidt S, Sedlacek L, Sitter H, Smaczny C, Tümmler B, Vonberg R, Wielpütz MO, Wilkens H, Wollschläger B, Zerlik J, Düesberg U, van Koningsbruggen-Rietschel S (2018) 
S3-Leitlinie: Lungenerkrankung bei Mukoviszidose, Modul 2: Diagnostik und Therapie bei der chronischen Infektion mit Pseudomonas aeruginosa [CF Lung Disease - a German S3 Guideline: Module 2: Diagnostics and Treatment in Chronic Infection with Pseudomonas aeruginosa].
Pneumologie 2018;72:347-392

Avramidou V, Hatziagorou E, Kampouras A, Hebestreit H, Kourouki E, Kirvassilis F, Tsanakas J (2017)
Lung clearance index (LCI) as a predictor of exercise limitation among CF patients.
Pediatr Pulmonol Epub ahead of print.

Ballmann M, Hubert D, Assael BM, Staab D, Hebestreit A, Naehrlich L, Nickolay T, Prinz N, Holl RW; CFRD Study Group (2017)
Repaglinide versus insulin for newly diagnosed diabetes in patients with cystic fibrosis: a multicentre, open-label, randomised trial.
Lancet Diabetes Endocrinol Nov 30 Epub ahead of print.

Radtke T, Hebestreit H, Gallati S, Schneiderman JE, Braun J, Stevens D, Hulzebos EH, Takken T, Boas SR, Urquhart DS, Lands LC, Tejero S, Sovtic A, Dwyer T, Petrovic M, Harris RA, Karila C, Savi D, Usemann J, Mei-Zahav M, Hatziagorou E, Ratjen F, Kriemler S; CFTR-Exercise study group (2017)
CFTR Genotype and Maximal Exercise Capacity in Cystic Fibrosis: A Cross-sectional Study.
Ann Am Thorac Soc Nov 15 Epub ahead of print.

Radtke T, Hebestreit H, Puhan MA, Kriemler S (2017)
The 1-min sit-to-stand test in cystic fibrosis - Insights into cardiorespiratory responses. J
Cyst Fibros 16:744-751.

Radtke T, Nevitt SJ, Hebestreit H, Kriemler S (2017)
Physical exercise training for cystic fibrosis.
Cochrane Database Syst Rev 11:CD002768.

Rueegg CS, Kriemler S, Zuercher SJ, Schindera C, Renner A, Hebestreit H, Meier C, Eser P, von der Weid NX (2017)
A partially supervised physical activity program for adult and adolescent survivors of childhood cancer (SURfit): study design of a randomized controlled trial NCT02730767.
BMC Cancer 17:822.

Segerer FJ, Biko J, Reiners C, Wirth C, Hebestreit H (2017)
Exercise-induced Hypoxemia in Juvenile Thyroid Carcinoma With Lung Metastases.
Pediatr Exerc Sci 29:361-370.

Veldhoen S, Weng AM, Knapp J, Kunz AS, Stäb D, Wirth C, Segerer F, Hebestreit H, Malzahn U, Köstler H, Bley TA (2017)
Self-gated Non-Contrast-enhanced Functional Lung MR Imaging for Quantitative Ventilation Assessment in Patients with Cystic Fibrosis.
Radiology 283:242-251.

Hatziagorou E, Kampouras A, Avramidou V, Georgopoulou V, Kirvasilis F, Kontouli K, Hebestreit H, Tsanakas J (2016)
Exercise responses are related to structural lung damage in CF pulmonary disease. Pediatr
Pulmonol 51:914-20.

Hebestreit H, Arets HG, Aurora P, Boas S, Cerny F, Hulzebos EH, Karila C, Lands LC, Lowman JD, Swisher A, Urquhart DS (2016)
Cystic Fibrosis Exercise Working Group. Authors' Reply.
Respiration 2016;92:63-4.

Jantzen A, Opoku-Pare M, Bieli C, Ruf K, Hebestreit H, Moeller A (2016)
Perspective on cystic fibrosis and physical activity: Is there a difference compared to healthy individuals?
Pediatr Pulmonol 51:1020-1030.

Kriemler S, Förster H, Radtke T, Gruber W, Ferrari R, Gunkel J, Schliessmann S, Marx-Berger D, Schulze S, Beneke R, Hebestreit H (2016)
Empfehlungen zur sportmedizinischen Untersuchung bei Kindern und Jugendlichen.
Kinderärztliche Praxis 6/2016, 87:374-385.

Kriemler S, Radtke T, Christen G, Kerstan-Huber M, Hebestreit H (2016)
Short-Term Effect of Different Physical Exercises and Physiotherapy Combinations on Sputum Expectoration, Oxygen Saturation, and Lung Function in Young Patients with Cystic Fibrosis.
Lung 194:659-64.

Leu T, Rauthe S, Wirth C, Simon HU, Kunzmann V, Hebestreit H, Kunzmann S (2016)
Ein T-Zell assoziiertes Hypereosinophilie-Syndrom (L-HES) als Differenzialdiagnose eines Asthma bronchiale.
Klin Padiatr 228:319-324.

Radtke T, Nolan SJ, Hebestreit H, Kriemler S (2016)
Physical exercise training for cystic fibrosis.
Paediatr Respir Rev 19:42-5.

Radtke T, Puhan MA, Hebestreit H, Kriemler S (2016)
The 1-min sit-to-stand test-A simple functional capacity test in cystic fibrosis?
J Cyst Fibros 15:223-6.

Bradley J, O´Neil B, Kent L, Hulzebos H, Hebestreit H (2015)
Physical activity assessment in cystic fibrosis: a position statement.
J Cyst Fibros 14:e25-32.

Burtin C, Hebestreit H (2015)
Rehabilitation in patients with chronic respiratory disease other than COPD: Exercise and physical activity interventions in Cystic Fibrosis and non-CF bronchiectasis Respiration 89:181-9.

Flume PA, Aitken ML, Bilton D, Agent P, Charlton B, Forster E, Fox H, Hebestreit H, Kolbe J, Zuckerman JB, Button B (2015)
Optimizing inhaled mannitol for cystic fibrosis in an adult population: a review.
Breathe 11:39-48.

Hebestreit H, Kriemler S, Radtke T (2015)
Exercise for all cystic fibrosis patients: is the evidence strengthening?
Curr Opin Pulm Med 2015; 21:591-5.

Hebestreit H, Arets HG, Aurora P, Boas S, Cerny F, Hulzebos EH, Karila C, Lands LC, Lowman JD, Swisher A, Urquhart DS; European Cystic Fibrosis Exercise Working Group (2015)
Statement on exercise testing in cystic fibrosis.
Respiration 90:332-51.

Lands LL, Hebestreit H (2015)
Exercise testing in cystic fibrosis, the what and how. In: Watson RR (Hrsg.): Diet and Exercise in Cystic Fibrosis.
Elsevier, Amsterdam 283-289.

Leu T, Simon HU, Hebestreit H, Kunzmann S (2015)
Die Hypereosinophilie-Syndrome (HES) im Kindesalter/The hypereosinophilic syndromes in childhood.
Klin Pädiatr 227:308-13.

Müller FM, Bend J, Huttegger I, Möller A, Schwarz C,  Abele-Horn M, Ballmann M,  Bargon J, Baumann I, Bremer W,  Bruns R, Brunsmann F, Fischer R, Geidel C, Hebestreit H, Hirche TO, Hogardt M, Illing S, Koitschev A, Kohlhäufl M, Mahlberg R, Mainz JG, Pfeiffer-Auler S, Puderbach M, Riedler J, Schulte-Hubbert B, Sedlacek L, Sitter H, Smaczny C, Staab D, Tümmler B, Vonberg RP, Wagner TOF, Zerlik J, Rietschel E (2015)
S3-Leitlinie Lungenerkrankung bei Mukoviszidose. Modul1: Diagnostik und Therapie nach dem ersten Nachweis von Pseudomonas aeruginosa.
Monatsschr Kinderheilkd 163(6):590–599.

Radtke T, Nolan SJ, Hebestreit H, Kriemler S (2015)
Physical exercise training for cystic fibrosis.
Cochrane Database Syst Rev 28;6:CD002768.

Roth K, Jain N, Schenk T, Hebestreit H (2015)
Bewegungsintervention bei Kindern in Förderschulen Einfluss auf die motorische Leistungsfähigkeit, den BMI und die Hautfaltendicke.
Sportwiss 45:20–30.

Roth K, Kriemler S, Lehmacher W, Ruf KC, Graf C, Hebestreit H (2015)
Effects of a physical activity intervention in preschool children.
Med Sci Sports Exerc 47:2542-51.

Swisher A, Hebestreit H, Mejia-Dawns A, Lowman JD, Gruber W, Nippins M, Alison J, Schneiderman J (2015)
Exercise and habitual physical activity for people with cystic fibrosis: Expert consensus, evidence-based guide for advising people.
Cardiopulm Phys Therap J 26:85-98.

Swisher A, Pepe A, Weckesser J, Orenstein D, Hebestreit H (2015)
Peak Aerobic capacity in adults with CF stratified by lung disease severity: a retrospective chart review.
Cardiopulm Phys Therap J 26:78-82.

Fischer A, Weick S, Ritter CO, Beer M, Wirth C, Hebestreit H, Jakob PM, Hahn D, Bley T, Köstler H (2014)
Self-gated non-contrast-enhanced functional lung imaging (SENCEFUL) using a quasi-random FLASH sequence and proton MRI.
NMR Biomed 27:907-17.

Hebestreit H. (2014)
Exercise in cystic fibrosis.
In: Mall MA, Elborn JS (Hrsg.): ERS monograph - Cystic Fibrosis. European Respiratory Society, Sheffield/UK 203-218.

Hebestreit H (2014)
Kriterien der Freistellung vom Schulsport. In: Schmitt H (Hrsg.): Sportorthopädie und -traumatologie im Kindes- und Jugendalter.
 Deutscher Ärzte-Verlag, Köln 45-49.

Hebestreit H, Schmid K, Kieser S, Junge S, Ballmann M, Roth K, Hebestreit A, Schenk T, Schindler C, Posselt HG, Kriemler S (2014)
Quality of life is associated with physical activity and fitness in cystic fibrosis.
BMC Pulmon Med 14:26.

Hirche TO, Knoop C, Hebestreit H, Shimmin D, Solé A, Elborn JS, Ellemunter H, Aurora P, Hogardt M,  Wagner TOF (2014)
 Practical guidelines: Lung transplantation in patients with cystic fibrosis.
Pulmon Med 2014:621342.

Meyer U, Schindler C, Zahner L, Ernst D, Hebestreit H, van Mechelen W, Brunner-La Rocca HP, Probst-Hensch N, Puder JJ, Kriemler S (2014)
Long-term effect of a school-based physical activity program on fitness and adiposity in children. A cluster-randomized controlled trial.
PLOS One 9:e87929.

Ruf K, Hebestreit H (2014)
Körperliche Aktivität und Belastungsuntersuchungen bei Mukoviszidose.
 Monatsschrift Kinderheilkunde 162:222-227.

Schmid K, Fink K, Holl RW, Hebestreit H, Ballmann M (2014)
Predictors for future cystic fibrosis-related diabetes by oral glucose tolerance test.
J Cyst Fibros 13:80-85.

Winkler BE, Tetzlaff K, Muth CM, Koch A, Georgieff M, Hebestreit H (2014)
Body temperature and heart rate in paediatric SCUBA dives.
Int Sport Med J 15:30-40.

Schmid K, Fink K, Holl RW, Hebestreit H, Ballmann M (2014)
Predictors for future cystic fibrosis-related diabetes by oral glucose tolerance test.
J Cyst Fibros 13:80-85.

Bilton D, Bellon G, Charlton B, Cooper P, De Boeck K, Flume PA, Fox HG, Gallagher CG, Geller DE, Haarman EG, Hebestreit HU, Kolbe J, Lapey A, Robinson P, Wu J, Zuckerman JB, Aitken ML; CF301 and CF302 Investigators (2013)
Pooled analysis of two large randomised phase III inhaled mannitol studies in cystic fibrosis.
J Cyst Fibros 12:367-76.

Hebestreit H, Sauer-Heilborn A, Fischer R, Käding M, Mainz JG (2013)
Effects of ivacaftor on severely ill patients with cystic fibrosis carrying a G551D mutation.
J Cyst Fibros 12:599-603.

Kriemler S, Kieser S, Junge S, Ballmann M, Hebestreit A, Schindler C, Stüssi C, Hebestreit H (2013)
Effect of supervised training on FEV1 in cystic fibrosis: A randomised controlled trial.
J Cyst Fibros 12:714-20.

Meyer U, Roth R, Zahner L, Gerber M, Puder JJ, Hebestreit H, Kriemler S (2013)
Contribution of physical education to overall physical activity.
Scand J Med Sci Sports 23:600-6.

Reiners C, Biko J, Haenscheid H, Hebestreit H, Kirinjuk S, Baranowski O, Marlowe RJ, Demidchik E, Drozd V, Demidchik Y (2013)
Twenty-five years after chernobyl: outcome of radioiodine treatment in children and adolescents with very high-risk radiation-induced differentiated thyroid carcinoma.
J Clin Endocrinol Metab 98:3039-48.

Aitken ML., Bellon G, De Boeck K, Flume PA, Fox HG, Geller DE, Haarman EC, Hebestreit HU, Lapey A, Schou IM, Zuckerman JB, Charlton B (2012)
Long-term inhaled dry powder mannitol in cystic fibrosis: an international randomized study.
Am J Respir Crit Care Med 185:645-652.

d'Alquen D, De Boeck K, Bradley J, Vávrová V, Dembski B, Wagner TO, Pfalz A, Hebestreit H (2012)
Quality assessment of expert answers to lay questions about cystic fibrosis from various language zones in Europe: the ECORN-CF project.
BMC Med Res Methodol 12:11.

Neubauer H, Wirth C, Ruf K, Hebestreit H, Beer M (2012)
Acute muscle trauma due to over-exercise in an otherwise healthy patient with cystic fibrosis. Case Reports in Pediatrics, Volume 2012,
Article ID 527989.

Ruf K, Fehn S, Bachmann M, Möller A, Roth K, Kriemler S, Hebestreit H (2012)
Validation of activity questionnaires in patients with cystic fibrosis by accelerometry and cycle ergometry.
BMC Med Res Methodol 12:43.

Winkler BE, Muth CM, Tetzlaff K (2012)
Should children dive with self-contained underwater breathing apparatus (SCUBA)?
Acta Paediatr 101:472-8.

Wirbelauer J, Bauer J, Hebestreit H, Thomas W (2012)
Plastic bronchitis 3 years after Fontan palliation.
Klin Padiatr 224:38-39.

Hebestreit H, Biko J, Drozd V, Demidchik Y, Burkhardt A, Trusen A, Beer M, Reiners C (2011)
Pulmonary fibrosis in youth treated with radioiodine for juvenile thyroid cancer and lung metastases after Chernobyl.
Eur J Nucl Med Mol Imaging 38:1683-1690.

Radike, K., H. Hebestreit (2011)
Klinische Aspekte des Doping – Pädiatrische Aspekte. In: Raschka C, Nowacki PE, Zichner L, MayR (Hrsg): Doping: Klinik-Wirkstoffe-Methoden-Prävention.
Schattauer Verlag, Stuttgart 99-103.

Radike K, Kunzmann S, Abele-Horn M, Beer M, Hebestreit H (2011)
Osteoarticular infection by Candida albicans in an infant with cystic fibrosis.
J Med Microbiol 60:1542-1545.

Radike K, Molz K, Holl RW, Poeter B, Hebestreit H, Ballmann M (2011)
Prognostic relevance of hypoglycemia following an oral glucose challenge for cystic fibrosis-related diabetes.
Diabetes Care 34:e43.

Ruf K, Hebestreit H (2011)
How to measure exercise performance.
Curr Respir Med Rev 7:73-77.

Winkler BE, Tetzlaff K, Muth CM, Paulat K, Hebestreit H (2011)
SCUBA-dive-related changes in heart rate in children.
Pediatr Exerc Sci 23:388-398.

Wirbelauer J, Hebestreit H, Marx A, Marc E, Speer CP (2011)
Familial pulmonary capillary hemangiomatosis early in life.
Case Reports Pulmonol Article ID 827591; 2011:827591.

Hebestreit H (2010)
Ergometrie in der Pädiatrie
In: Löllgen H, Erdmann E, Gitt A (Hrsg): Ergometrie - Belastungsuntersuchungen in Klinik und Praxis, 3. Auflage. Springer Verlag, Berlin 313-328.

Hebestreit H, Kieser S, Junge S, Ballmann M, Hebestreit A, Schindler C, Schenk T, Posselt HG, Kriemler S (2010)
Long-term effects of a partially supervised conditioning programme in cystic fibrosis.
Eur Respir J 35: 578-583.

Hirche TO, Bradley J, d'Alquen D, De Boeck K, Dembski B, Elborn JS, Gleiber W, Lais C, Malfroot A, Wagner TO (2010)
Travelling with cystic fibrosis: recommendations for patients and care team members.
J Cyst Fibros 9: 385-399.

Kriemler S, Zahner L, Schindler C, Meyer U, Hartmann T, Hebestreit H, Brunner-La Rocca HP, van Mechelen W, Puder JJ (2010)
Effect of school based physical activity programme (KISS) on fitness and adiposity in primary schoolchildren: cluster randomised controlled trial.
Bmj 340:c785.

Kunzmann S, Thomas W, Mayer B, Kuhn S, Hebestreit H (2010)
Immune-mediated severe hemolytic crisis with a hemoglobin level of 1.6 g/dl caused by anti-piperacillin antibodies in a patient with cystic fibrosis.
Infection 38:131-134.

Muthig M, Hebestreit A, Ziegler U, Seidler M, Muller FM (2010)
Persistence of Candida species in the respiratory tract of cystic fibrosis patients.
Med Mycol 48:56-63.

Roth K, Mauer S, Obinger M, Ruf KC, Graf C, Kriemler S, Lenz D, Lehmacher W, Hebestreit H (2010)
Prevention through Activity in Kindergarten Trial (PAKT): a cluster randomised controlled trial to assess the effects of an activity intervention in preschool children.
BMC Public Health 10:410.

Roth K, Mauer S, Obinger M, Hebestreit H (2010)
Prävention durch Bewegung und Sport im Kindergarten.
Public Health Forum 18:24-26.

Roth K, Ruf K, Obinger M, Mauer S, Ahnert J, Schneider W, Graf C, Hebestreit H (2010)
Is there a secular decline in motor skills in preschool children?
Scand J Med Sci Sports 20:670-678.

Ruf K, Winkler B, Hebestreit A, Gruber W, Hebestreit H (2010)
Risks associated with exercise testing and sports participation in cystic fibrosis.
J Cyst Fibros 9:339-345.

Sturm A, Hebestreit H, Koenig C, Walter U, Grossmann R (2010)
Platelet proinflammatory activity in clinically stable patients with CF starts in early childhood.
J Cyst Fibros 9:179-186.

Valenza G, Radike K, Schoen C, Horn S, Oesterlein A, Frosch M, Abele-Horn M, Hebestreit H (2010)
Resistance to tobramycin and colistin in isolates of Pseudomonas aeruginosa from chronically colonized patients with cystic fibrosis under antimicrobial treatment.
Scand J Infect Dis 42: 885-889.

Winkler BE, Tetzlaff K, Muth CM, Hebestreit H (2010)
Pulmonary function in children after open water SCUBA dives.
Int J Sports Med 31: 724-730